The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
My last post today I promise
This has just come to my attention this avo
It is yet another newly listed SPAC focused in mining sector, so apologies in advance to those now sick to death of these...
Some early info
https://www.proactiveinvestors.com/companies/news/948406/east-star-resources-lists-in-london-backed-by-mining-veterans-948406.html
It only got listed yesterday and Twitterati are already ramping it and it has spiked this morning to almost 100% of placing price, so consider it Already in hype stock category
Just adding to my ever growing watchlist for now, whilst I research more and take learnings from previous hype SPAC entries
Have a Nice evening
Thanks 1509. - Very helpful
Don’t want to sound too sound %ve here, 2 big probs with BRH Sp action
All the recent director sells in April In 60s and that massive gap in Dec.
If the gap is attempted to be filled, even partially this could go down to as low as 30s imo.
Be extra vigilant and if need be even consider stop losses here if your in at 50 mark.
This one is not one for faint hearted when going up or down
Best of luck peeps
Small favour please.
Could someone with L2, let me know which MM controlling bid right now. - is it PEEL by any chance?
Ta
M
Just Remember 3 day golden rule to allow for those pesky margin sellers to get out.
Look at SNG....
Tbh 1509. Season was a right off for me once new year started And form went south.. Just glad we got rid of Mourinho in the end as football quality was pretty poor from us in the main
West Ham deserve Europe and then Liv, Eve and us for last spot. But If Ars reach Europa cup final and beat Man Utd I will be disgusted ...
Fek- keep resilient bud, mkt is getting tougher and need to pick sectors and co’s carefully now.
Oil and metals are looking strong and still opps out there
oex and sav are my tips for good returns in next 4-6 weeks to help claw back some of those Ls.
Check em out.
To dare is to do - And yes I am a Spurs fan for my sins
Atb
Hey FEk - I’m of view that CBD will be big in H2 this year.
I decided to cut my losses early April on CbX and MXC once I realised mkt sentiment And liquidity had moved away and I switched into commodites stocks for first time as I saw more immediate opportunities and potential there
At the mo, the CBD stocks are trading 20% lower than when sold, and I’m up a quite a bit on commodities, so it working out for me.
But am def keeping a close eye as plan to go back in when sentiment switches and news flow start to happen. Maybe Jun / July.
That’s a defo buy in that range imo.
It’s currently churning an overhang of 1bn shares that are being exercised in 2 traches in May.
Once overhang is done this will do a RMM and double up back to 50p. News will also come to confirm Cambay deal complete to support rise
oEx will be one of my pics for June comp
Well , at least give u a chance to practice Another falling knife snap back trade if you want....
Ok. This time I’m gonna try a combo of bullish TA charts + fundamentals to choose my pick.
MHC - price action on run up to 17 May and expectation of further relaxation of lockdown are opening up of travel abroad
CMRS - news due end of month of further drill results
STX- News update due mid May on progress around launch of Accrufer in US planned for end of June
Anyone follow these ?
Would highly recommend today’s one mainly for Special Guest David Lenigas. The input from this guy was very insightful indeed. At least It was was for me anyway.
Nol - agree with you re chart support levels.
Other thing to add is with falling knife there is 3 day golden rule which pro traders talk about before a snap back.
Use NCYT as an example which also announced on Friday before their falling knife. I expect Tue to be very volatile and still bearish. Then Wed / Thu would be the snap back Window
Buy zone to me should be anywhere around 100 mark and anything lower is an added bonus. Should snap back to top of gap next week of 120 maybe up to 130 which should be short term Exit trade zone with a 20% plus move.
Beyond that I see this drift again back down as next news is Phase 3 which is not Expected now until H2.
GL
My tuppence worth here...
Whilst on face of it, the home trials data results indicate that SNG016 has greatest success with more severe symptoms of breathlessness and therefore would only be prescribed to a far smaller target popn displaying such symptoms . But when you look at India and Brazil which are very populous countries. Even 1-2% of severe cases displaying these symptoms would still be a very siginificant number to treat
There has also been lots of Covid data , pointing to the fact that those in ethnic minorities have a higher rate of severe cases and mortality, so I definitely believe in places like India and other Afirican countries there may well be a much higher incidence of effectiveness of this drug in any case and even in lower age groups
You may well find for example, that rate of severe Covid cases and mortality rate in say over 50s in India or Africa could well Be higher vs over 80s in U.K, due to higher poverty levels, poorer hygiene ,Malnutrition and high pollution, etc. These are all contributing health factors imo.
Therefore It would Not surprise me that phase 3 results and drug effectiveness may well vary Considerably between developed and developing countries, and it is of great advantage that SNG is able to a world wide study across all continents as it could highlight this fact.
.
Hey Xv,
Re RDGC, What I can say is that there is close network of directors who are part of AAA and Vela which invested in high tech companies either already floated or are private and pre IPO and these same directors have all formed SPACs in Q1 this yearr. So this is where the intrigue here as notion is, is that potentially some of Rto opps may come from these private companies which had Leary investment and could be floated via SPACs as vehicle to IPO quickly and more cheaply (less reg requirements using a SpAC to float a company via a rto.)
In terms of QTZ, this has a very strong BOD as it is, which Simon Grant Reniick was originally part of,, but then left, to follow up on other opps , , but still hold a secent share holding . But Chris Akers is main draw to this SPAC for following reason.
.1. He is a seriously rich pro- investor And has made most of his wealth thru concentrated astute investments. His investment in AAA alone is worth over £50m
2 He has openly said that secret to his success is investing in companies where he knows both the company, sector and its peer group very well thus thorough research and companies ambitions ties in with his own. In other words, he will have close ties with BoDs and will most prob have influence on strategy and direction of QTZ given his huge knowledge and experience in sector as well as his Huge holding.
3.All of his known investment right now are closely tied together in high tech sectors these include AAA, PIRI, Gunsynd, Asimilar Group BrandShield, so an ipo could be linked to One of these
All of the above suggest QTZ is a loaded bet imo.
Good luck
The 60% spike on no news looks exaggerated and suggests a total pump n dump play by pro traders jumping on rumour mill and fomo before bank holiday weekend.
But interesting that no speeding ticket has been issued by nomad today which is normally the case with big jumps on no news.
their last RNS It clearly stated that any rto would need to happen at or less than 3 x NAv- We’re around this level now - so is there a leak?
SNG home study results were not as expected.
Although they tatgetted the perceived more vulnerable over 60s there wasn’t a great deal of difference in recovery from treated group. Vs placebo This is cos most of this group didn’t appear to have severe symptoms manifest once they contracted Covid with only 2 going into hospital from placebo group and recovering.
A small minority had more severe symptoms of breathlessness and this is where the drug showed most imorovement and Phase 3 is targeting these more severe case for their trial,
However, P3 data won’t be ready till H2, and even if resits are positive , it will likely be too late to be commercially rolled to treat wave 2 and to help all those poor souls in India and Brazil right now.. Such a shame
Woah.
AAA has been temporarily suspended from Trading in advance of announcement re:
AAQUA and MESH,
Any indirect links here I wonder.....?
Linked to post from Bebeto, here is some earlier news posted back in Feb, referencing an IPO of Aeristech and the links to Vela BoD
https://www.londonstockexchange.com/news-article/VELA/350-000-pre-ipo-investment-in-aeristech/14879254?lang=en
Note pre- IPo valuation of Aeritech......
Interestingly on MOGP old website they have their shareholder register updates as @ 16 Mar, just 3 days older than UK SPAC and Raglan is still showing with other TR1 holders.
http://www.mountfieldgroupplc.com/investors/shareholder-information.html
None of these appear on UKSPAC website , so I guess They must have all been bundled in under the larger nominee summaries.....?